Open AccessA brief introduction to institutional review boards in the United States
Author(s) -
Qiao Haiping
Publication year - 2018
Publication title -
pediatric investigation
Language(s) - English
Resource type - Journals
ISSN - 2574-2272
DOI - 10.1002/ped4.12023
Subject(s) - institutional review board , china , drug trial , clinical trial , political science , medicine , ethics committee , engineering ethics , family medicine , compliance (psychology) , medical education , law , public administration , psychology , pathology , engineering , psychiatry , social psychology
China has become one of the main fields for international drug and device trials in the last twenty years. Although China has greatly strengthened the protection of human research participants over this time, there is still room for improvement. In order for Chinese investigators to participate in international clinical trials, compliance with internationally recognized ethical regulations is essential. In the United States (U.S.), research involving human subjects is reviewed by an ethics committee called the Institutional Review Board ( IRB ). In this article, we briefly introduce the background, composition, and function of the IRB in the U.S. to our Chinese investigators.